Outcomes After Virologic Failure of First-Line ART in South Africa

Murphy, Richard A; Sunpath, Henry; Lu, Zhigang; Chelin, Neville; Losina, Elena; Gordon, Michelle; Ross, Douglas; Ewusi, Aba D; Matthews, Lynn T; Kuritzkes, Daniel R; Marconi, Vincent C

dc.contributor.author	Murphy, Richard A	*
dc.contributor.author	Sunpath, Henry	*
dc.contributor.author	Lu, Zhigang	*
dc.contributor.author	Chelin, Neville	*
dc.contributor.author	Losina, Elena	*
dc.contributor.author	Gordon, Michelle	*
dc.contributor.author	Ross, Douglas	*
dc.contributor.author	Ewusi, Aba D	*
dc.contributor.author	Matthews, Lynn T	*
dc.contributor.author	Kuritzkes, Daniel R	*
dc.contributor.author	Marconi, Vincent C	*
dc.date.accessioned	2012-12-11T23:38:27Z
dc.date.available	2012-12-11T23:38:27Z
dc.date.issued	2010-04-24
dc.date.submitted	2011-03-22
dc.identifier.citation	AIDS;2010;24(7):1007-12	en
dc.identifier.issn	1473-5571
dc.identifier.pmid	20397305
dc.identifier.uri	http://hdl.handle.net/10144/255398
dc.description	Article approval pending
dc.description.abstract	To determine initial 24-week outcomes among prospectively enrolled patients with failure of initial antiretroviral therapy (ART).
dc.language.iso	en	en
dc.relation.url	http://journals.lww.com/aidsonline/Abstract/2010/04240/Outcomes_after_virologic_failure_of_first_line_ART.9.aspx	en
dc.rights	Published by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluwer	en
dc.subject.mesh	Adult	en
dc.subject.mesh	Anti-HIV Agents	en
dc.subject.mesh	Anti-Retroviral Agents	en
dc.subject.mesh	CD4 Lymphocyte Count	en
dc.subject.mesh	Drug Resistance, Viral	en
dc.subject.mesh	Female	en
dc.subject.mesh	Genotype	en
dc.subject.mesh	HIV Infections	en
dc.subject.mesh	HIV-1	en
dc.subject.mesh	Humans	en
dc.subject.mesh	Male	en
dc.subject.mesh	Middle Aged	en
dc.subject.mesh	Mutation	en
dc.subject.mesh	Prospective Studies	en
dc.subject.mesh	South Africa	en
dc.subject.mesh	Treatment Failure	en
dc.subject.mesh	Viral Load	en
dc.title	Outcomes After Virologic Failure of First-Line ART in South Africa	en
dc.type	Article	en
dc.contributor.department	Operational Support Unit, Doctors Without Borders, New York, New York; McCord Hospital, Durban, South Africa; Massachusetts General Hospital, Boston, Massachusetts, USA; Nelson Mandela School of Medicine, Durban; St. Mary’s Hospital, Mariannhill, South Africa; Harvard Medical School; Division of Infectious Diseases, Beth Israel Deaconess Medical Center; Section of Retroviral Therapeutics, Brigham and Women’s Hospital, Boston, Massachusetts; Infectious Disease Service, San Antonio Military Medical Center, Fort Sam Houston, Texas; Emory University School of Medicine, Atlanta, Georgia, USA	en
dc.identifier.journal	AIDS	en
refterms.dateFOA	2019-03-04T10:07:45Z
html.description.abstract	To determine initial 24-week outcomes among prospectively enrolled patients with failure of initial antiretroviral therapy (ART).